American Journal of Cardiology
Volume 104, Issue 1 , Pages 1-4 , 1 July 2009

Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)

  • William E. Boden, MD

      Affiliations

    • VA Western New York Health Care System, Buffalo General Hospital, and the University at Buffalo, Buffalo, New York
    • Corresponding Author InformationCorresponding author: Tel: 716-859-1784; fax: 716-859-3765
    • ,
  • Robert A. O'Rourke, MD

      Affiliations

    • VA South Texas Health Care System, San Antonio, Texas
    • ,
  • Koon K. Teo, MB, BCh, PhD

      Affiliations

    • McMaster University Medical Center, Hamilton, Ontario, Canada
    • ,
  • David J. Maron, MD

      Affiliations

    • Vanderbilt University Medical Center, Nashville, Tennessee
    • ,
  • Pamela M. Hartigan, PhD

      Affiliations

    • VA Cooperative Studies Program Coordinating Center and VA Connecticut Health Care System, West Haven, Connecticut
    • ,
  • Steven P. Sedlis, MD

      Affiliations

    • Veterans Affairs New York Harbor Health Care System and New York University School of Medicine, New York, New York
    • ,
  • Marcin Dada, MD

      Affiliations

    • Hartford Hospital, Hartford, Connecticut
    • ,
  • Mohammed Labedi, MD

      Affiliations

    • VA Western New York Health Care System, Buffalo General Hospital, and the University at Buffalo, Buffalo, New York
    • ,
  • John A. Spertus, MD, MPH

      Affiliations

    • Mid America Heart Institute, Kansas City, Missouri
    • ,
  • William J. Kostuk, MD

      Affiliations

    • London Health Sciences Centre, London, Ontario, Canada
    • ,
  • Daniel S. Berman, MD

      Affiliations

    • Cedars-Sinai Medical Center, Los Angeles, California
    • ,
  • Leslee J. Shaw, PhD

      Affiliations

    • Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Bernard R. Chaitman, MD

      Affiliations

    • St. Louis University, St. Louis, Missouri
    • ,
  • G.B. John Mancini, MD

      Affiliations

    • University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • William S. Weintraub, MD

      Affiliations

    • Christiana Care Health System, Newark, Delaware
    • ,
  • COURAGE Trial Investigators

Received 22 December 2008 ,Revised 20 February 2009 ,Accepted 20 February 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was sponsored by the Department of Veterans Affairs Cooperative Studies Program. Additional funding was provided by the Canadian Institutes of Health Research. Supplemental corporate support from several pharmaceutical companies included funding and in-kind support. All support from the pharmaceutical industry consisted of unrestricted research grants payable to the Department of Veterans Affairs.

PII: S0002-9149(09)00661-4

doi: 10.1016/j.amjcard.2009.02.059

American Journal of Cardiology
Volume 104, Issue 1 , Pages 1-4 , 1 July 2009

Article Tools

* Image Usage & Resolution